Goldman Sachs’s Foundation Medicine, Inc. FMI Stock Holding History

Goldman Sachs’s Portfolio FMI Stock Details FMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-18,200	Closed	-$2.49M	–	5973
2018 Q2	$2.49M	Sell	18,200 -101,800	-85%	-$9.25M	﹤0.01%	3491
2018 Q1	$9.45M	Buy	+120,000	New	+$8.85M	﹤0.01%	2373
2016 Q1	–	Sell	-48,600	Closed	-$1.02M	–	7469
2015 Q4	$1.02M	Buy	+48,600	New	+$937K	﹤0.01%	4271
2015 Q2	–	Sell	-50,000	Closed	-$2.41M	–	7560
2015 Q1	$2.41M	Hold	50,000	–	–	﹤0.01%	3597
2014 Q4	$1.11M	Hold	50,000	–	–	﹤0.01%	4453
2014 Q3	$948K	Hold	50,000	–	–	﹤0.01%	4667
2014 Q2	$1.35M	Hold	50,000	–	–	﹤0.01%	4414
2014 Q1	$1.62M	Buy	+50,000	New	+$1.62M	﹤0.01%	4180

Goldman Sachs's FMI Position: Q3 2018 in Review

Goldman Sachs sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 170,797 shares — an estimated $23.3M sold.

Goldman Sachs first reported a position in FMI in Q4 2013 and held it in 18 quarters. The position peaked at $23.3M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

Goldman Sachs reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
Goldman Sachs sold 170,797 Foundation Medicine, Inc. shares in Q3 2018, an estimated $23.3M.
Goldman Sachs first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 18 quarters.
Goldman Sachs's Foundation Medicine, Inc. position peaked at $23.3M in Q2 2018.
0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on Goldman Sachs's 13F filing for Q3 2018, filed 14 Nov 2018.